Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single-center, open-label, prospective randomized study
- PMID: 31794152
- DOI: 10.1111/1744-9987.13461
Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single-center, open-label, prospective randomized study
Abstract
The efficacy and safety of zinc acetate hydrate (ZAH) for zinc supplementation in patients on maintenance hemodialysis (MHD) remains unknown. In this prospective, single-center, open-label, parallel-group trial for MHD patients with serum zinc level <70 μg/dL, we compared ZAH (zinc; 50 mg/day) and polaprezinc (PPZ; zinc; 34 mg/day) beyond 6-month administration in a 1:1 randomization manner. The ZAH and PPZ groups had 44 and 47 patients, respectively. At 3 months, the change rate of serum zinc levels in the ZAH group was significantly higher than that in the PPZ group. Three months after the study, serum copper levels significantly decreased in the ZAH group, but not in the PPZ group. No significant differences were noted in anemia management in either group. ZAH was superior to PPZ in increasing serum zinc levels. Clinicians should note the stronger decline in serum copper levels when using ZAH for MHD patients.
Keywords: hemodialysis; polaprezinc; renal anemia; zinc acetate hydrate; zinc supplementation.
© 2019 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.
Similar articles
-
Retrospective study on the therapeutic efficacy of zinc acetate hydrate administration to patients with hypozincemia-induced dysgeusia.BMC Oral Health. 2023 Mar 18;23(1):159. doi: 10.1186/s12903-023-02866-7. BMC Oral Health. 2023. PMID: 36934261 Free PMC article.
-
Zinc Acetate Hydrate Supplementation versus Polaprezinc Supplementation for Improving Hypozincemia in Hemodialysis Patients: A Randomized Clinical Trial.Int J Nephrol. 2023 Oct 5;2023:2403755. doi: 10.1155/2023/2403755. eCollection 2023. Int J Nephrol. 2023. PMID: 37840640 Free PMC article.
-
Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis.Clin Exp Nephrol. 2020 Oct;24(10):955-962. doi: 10.1007/s10157-020-01911-x. Epub 2020 Jun 15. Clin Exp Nephrol. 2020. PMID: 32557260 Clinical Trial.
-
Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data.Nutrients. 2020 Apr 17;12(4):1128. doi: 10.3390/nu12041128. Nutrients. 2020. PMID: 32316581 Free PMC article.
-
Applicability of zinc complex of L-carnosine for medical use.Biochemistry (Mosc). 2000 Jul;65(7):817-23. Biochemistry (Mosc). 2000. PMID: 10951100 Review.
Cited by
-
Association Between the Blood Copper-Zinc (Cu/Zn) Ratio and Anemia in Patients Undergoing Maintenance Hemodialysis.Biol Trace Elem Res. 2022 Jun;200(6):2629-2638. doi: 10.1007/s12011-021-02888-8. Epub 2021 Sep 4. Biol Trace Elem Res. 2022. PMID: 34480666
-
Retrospective study on the therapeutic efficacy of zinc acetate hydrate administration to patients with hypozincemia-induced dysgeusia.BMC Oral Health. 2023 Mar 18;23(1):159. doi: 10.1186/s12903-023-02866-7. BMC Oral Health. 2023. PMID: 36934261 Free PMC article.
-
Zinc Acetate Hydrate Supplementation versus Polaprezinc Supplementation for Improving Hypozincemia in Hemodialysis Patients: A Randomized Clinical Trial.Int J Nephrol. 2023 Oct 5;2023:2403755. doi: 10.1155/2023/2403755. eCollection 2023. Int J Nephrol. 2023. PMID: 37840640 Free PMC article.
-
Oral adverse events due to zinc deficiency after pancreaticoduodenectomy requiring continuous intravenous zinc supplementation: a case report and literature review.BMC Oral Health. 2022 Mar 3;22(1):52. doi: 10.1186/s12903-022-02088-3. BMC Oral Health. 2022. PMID: 35241043 Free PMC article. Review.
-
Zinc Deficiency in Chronic Kidney Disease and Hemodialysis: Insights from Basic Research to Clinical Implications.Nutrients. 2025 Jun 30;17(13):2191. doi: 10.3390/nu17132191. Nutrients. 2025. PMID: 40647294 Free PMC article. Review.
References
REFERENCES
-
- Imanishi M, Hori Y, Nagaoka M, Sugiura Y. Design of novel zinc finger proteins: Towards artificial control of specific gene expression. Eur J Pharm Sci. 2001;13:91-97.
-
- Kobayashi H, Abe M, Okada K, et al. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis. Nutrients. 2015;7:3783-3795.
-
- Bromley SM. Smell and taste disorders: A primary care approach. Am Fam Physician. 2000;61:427-436. 438.
-
- Wang L-J, Wang M-Q, Hu R, et al. Effect of zinc supplementation on maintenance Hemodialysis patients: A systematic review and meta-analysis of 15 randomized controlled trials. Biomed Res Int. 2017;2017:1-11.
-
- Osawa M, Yamaguchi T, Nakamura Y, et al. Erythroid expansion mediated by the Gfi-1B zinc finger protein: Role in normal hematopoiesis. Blood. 2002;100:2769-2777.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical